Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) — Cash Flow Reinvestment Rate
Latest as of September 2025:
0.00x
Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) has a Cash Flow Reinvestment Rate of 0.00x as of September 2025, reinvesting $4.00 (capex $4.00 ) from operating cash flow of $137.91K. Explore Drugs Made In America Acquisition Corp. capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
$4.00
Capex + Investments
Operating Cash Flow
$137.91K
USD
Capital Expenditures
$4.00
USD
Annual Cash Flow Reinvestment Rate for Drugs Made In America Acquisition Corp. Ordinary Shares (None–None)
Year-by-year capital reinvestment analysis for Drugs Made In America Acquisition Corp. Ordinary Shares. For live market cap and broader valuation context, see DMAA company net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow